Literature DB >> 22087434

Bioactive substances with anti-neoplastic efficacy from marine invertebrates: Bryozoa, Mollusca, Echinodermata and Urochordata.

Peter Sima1, Vaclav Vetvicka.   

Abstract

The marine environment provides a rich source of natural products with potential therapeutic application. This has resulted in an increased rate of pharmaceutical agents being discovered in marine animals, particularly invertebrates. Our objective is to summarize the most promising compounds which have the best potential and may lead to use in clinical practice, show their biological activities and highlight the compounds currently being tested in clinical trials. In this paper, we focused on Bryozoa, Mollusca, Echinodermata and Urochordata.

Keywords:  Cancer; Echinodermata; Invertebrates; Mollusca; Urochordata

Year:  2011        PMID: 22087434      PMCID: PMC3212817          DOI: 10.5306/wjco.v2.i11.362

Source DB:  PubMed          Journal:  World J Clin Oncol        ISSN: 2218-4333


  43 in total

1.  Jorunnamycins A-C, new stabilized renieramycin-type bistetrahydroisoquinolines isolated from the Thai nudibranch Jorunna funebris.

Authors:  Kornvika Charupant; Khanit Suwanborirux; Surattana Amnuoypol; Emi Saito; Akinori Kubo; Naoki Saito
Journal:  Chem Pharm Bull (Tokyo)       Date:  2007-01       Impact factor: 1.645

2.  Marine Natural Products as Inhibitors of Hypoxic Signaling in Tumors.

Authors:  Dale G Nagle; Yu-Dong Zhou
Journal:  Phytochem Rev       Date:  2009-06       Impact factor: 5.374

3.  Phase I study of bryostatin 1 and gemcitabine.

Authors:  Basil F El-Rayes; Shirish Gadgeel; Anthony F Shields; Stephanie Manza; Patricia Lorusso; Philip A Philip
Journal:  Clin Cancer Res       Date:  2006-12-01       Impact factor: 12.531

4.  The action of bryostatin on normal human hematopoietic progenitors is mediated by accessory cell release of growth factors.

Authors:  S J Sharkis; R J Jones; M L Bellis; G D Demetri; J D Griffin; C Civin; W S May
Journal:  Blood       Date:  1990-08-15       Impact factor: 22.113

5.  Oyster (Crassostrea gigas) hydrolysates produced on a plant scale have antitumor activity and immunostimulating effects in BALB/c mice.

Authors:  Yu-Kai Wang; Hai-Lun He; Guo-Fan Wang; Hao Wu; Bai-Cheng Zhou; Xiu-Lan Chen; Yu-Zhong Zhang
Journal:  Mar Drugs       Date:  2010-02-02       Impact factor: 5.118

Review 6.  Toxins from ascidians.

Authors:  D J Watters; A L Van Den Brenk
Journal:  Toxicon       Date:  1993-11       Impact factor: 3.033

Review 7.  Aplyronine A, a potent antitumour macrolide of marine origin, and the congeners aplyronines B-H: chemistry and biology.

Authors:  Kiyoyuki Yamada; Makoto Ojika; Hideo Kigoshi; Kiyotake Suenaga
Journal:  Nat Prod Rep       Date:  2009-01       Impact factor: 13.423

8.  Potent cytotoxins produced by a microbial symbiont protect host larvae from predation.

Authors:  Nicole Lopanik; Niels Lindquist; Nancy Targett
Journal:  Oecologia       Date:  2004-01-28       Impact factor: 3.225

9.  A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma.

Authors:  F H Blackhall; M Ranson; J A Radford; B W Hancock; M Soukop; A T McGown; A Robbins; G Halbert; G C Jayson
Journal:  Br J Cancer       Date:  2001-02       Impact factor: 7.640

10.  Anticancer alkaloid lamellarins inhibit protein kinases.

Authors:  Dianne Baunbaek; Nolwenn Trinkler; Yoan Ferandin; Olivier Lozach; Poonsakdi Ploypradith; Somsak Rucirawat; Fumito Ishibashi; Masatomo Iwao; Laurent Meijer
Journal:  Mar Drugs       Date:  2008-10-07       Impact factor: 5.118

View more
  1 in total

1.  Screening of antiangiogenic potential of twenty two marine invertebrate extracts of phylum Mollusca from South East Coast of India.

Authors:  Pankaj Gupta; Muthuvel Arumugam; Raj Vardhan Azad; Rohit Saxena; Supriyo Ghose; Nihar Ranjan Biswas; Thirumurthy Velpandian
Journal:  Asian Pac J Trop Biomed       Date:  2014-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.